Details for 2016852640
Up to date per 09.04.2026
Actions
Details for 2016852640
Granted/Registered
European Patent
08.08.2018 A
28.04.2021 B1
01.10.2015
US
201562235900 P
C07D 471/04 20060101AFI20190502BHEP
Owner
Olema Pharmaceuticals, Inc.512 2nd Street, 4th Floor San Francisco, CA 94107US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
MYLES, David, C.79 Roble Road Berkeley, CA 94705US
KUSHNER, Peter, J.1362 6th Avenue San Francisco, CA 94122US
HARMON, Cyrus, L.PO Box 219 Bolinas, CA 94924US
Information about Fees